Q4 2022 Holdings
Filed 2023-02-14 | 25 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moderna Inc(MRNA) | COM | 60770K107 | $2.3B | 12,886,743 | 73.9% |
| Omega Therapeutics Inc | COM | 68217N105 | $293.5M | 25,902,269 | 9.4% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $135.2M | 34,239,018 | 4.3% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $129.5M | 23,117,045 | 4.1% |
| Evelo Biosciences Inc | COM | 299734103 | $81.2M | 50,427,328 | 2.6% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $80.9M | 12,674,120 | 2.6% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $72.9M | 2,619,968 | 2.3% |
| Axcella Health Inc | COM | 05454B105 | $9.4M | 29,251,545 | 0.3% |
| Rubius Therapeutics Inc | COM | 78116T103 | $6.5M | 38,506,526 | 0.2% |
| Sigilon Therapeutics Inc | COM | 82657L107 | $3.6M | 10,370,369 | 0.1% |
| Syros Pharmaceuticals Inc(SYRS) | COM | 87184Q206 | $3.6M | 993,848 | 0.1% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $1.4M | 3,540,636 | 0.0% |